Dana Farber Cancer Institute ( Site 1105)

Boston, Massachusetts 02215

1 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) — Recruiting now